glp 1 agonist fda approved for weight loss Is Semaglutide GLP-1 Safe Loss? Novel oral GLP-1 receptor agonist

Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality

There is no argument that the drugs are much more potent and faster acting than your bodies natural GLP-1 hormones

Participants 43365 adults (18 years) with type 2 diabetes who used a GLP-1 receptor agonist or SGLT-2 inhibitor within 30 days before upper gastrointestinal endoscopy

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeuti...

This article explores current clinical evidence, provider decision-making frameworks, and how genetic insights may inform a personalized conversation with your healthcare

An obesity medicine specialist explains why thats not a good idea.